Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating androgen signaling tumor dependency with host neuroendocrine immunity for glioblastoma therapies.

Neuro-oncology·2026
Same author

GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells.

Nature cancer·2026
Same author

DeepFaceMouse enables scalable prediction of large-scale brain activity from facial dynamics in mice.

Cell reports methods·2026
Same author

NeuroPupil: A generalization-first framework for scalable and biologically informative cross-species pupillometry.

bioRxiv : the preprint server for biology·2026
Same author

Corrigendum to "Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal" [Experimental Neurology, vol. 213,1 (2008): 114-21].

Experimental neurology·2026
Same author

Females experience a greater benefit from surgical resection in an immune-dependent manner in a preclinical glioblastoma model.

Neuro-oncology advances·2026

Related Experiment Video

Updated: Mar 20, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K

Reporter Systems to Study Cancer Stem Cells.

Caner Saygin1, Mohamed Samour1,2, Anastasia Chumakova1

  • 1Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, NC 10, Cleveland, OH, 44195, USA.

Methods in Molecular Biology (Clifton, N.J.)
|May 26, 2016
PubMed
Summary

Reporter technologies help isolate and track cancer stem cells (CSCs) in real time across various cancer models. This review details the current state, applications, and limitations of these essential tools in cancer research.

Keywords:
Cancer stem cellsNANOGPluripotency transcription factorReporterTumor heterogeneity

More Related Videos

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples
09:57

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples

Published on: May 10, 2017

8.1K
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

5.2K

Related Experiment Videos

Last Updated: Mar 20, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K
Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples
09:57

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples

Published on: May 10, 2017

8.1K
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

5.2K

Area of Science:

  • Oncology
  • Cell Biology
  • Biotechnology

Background:

  • Cancer stem cells (CSCs) are crucial for tumor initiation and progression.
  • CSCs have been identified across diverse cancer types, including primary tumors and cell lines.
  • Tracking CSCs is vital for understanding cancer biology and developing effective therapies.

Purpose of the Study:

  • To review the current landscape of reporter technologies for cancer stem cells.
  • To highlight the applications of these reporters in cancer research.
  • To discuss the limitations and future directions of CSC reporter development.

Main Methods:

  • Literature review of studies utilizing reporter systems for cancer stem cells.
  • Analysis of reporter gene applications in various cancer models (in vitro and in vivo).
  • Evaluation of the advantages and disadvantages of different reporter strategies.

Main Results:

  • Reporter systems enable efficient enrichment and real-time tracking of CSCs.
  • Various reporter types (fluorescent proteins, enzymes, etc.) are employed across multiple cancer types.
  • Current reporters offer valuable insights but have limitations in sensitivity and specificity.

Conclusions:

  • Reporter technologies are indispensable tools for studying cancer stem cells.
  • Continued innovation in reporter design is needed to overcome existing limitations.
  • Advanced reporter systems will accelerate the development of targeted cancer therapies.